Skubitz A

ORCID: 0000-0003-4672-3450 · 5 papers in corpus
diagnostic-accuracy 2026
Clinical proteomics ·doi:10.1186/s12014-026-09610-7

BACKGROUND: Earlier detection is strongly associated with increased survival for women with ovarian cancer. Unfortunately, current screening strategies, employing serial serum or ultrasound assessments, lack adequate sensitivity and specifi…

nonrandomized-trial 2025
Clinical cancer research : an official journal of the American Association for Cancer Research ·doi:10.1158/1078-0432.ccr-25-1878

PURPOSE: To evaluate exemestane, an aromatase inhibitor, as a preventive intervention for endometrial cancer. EXPERIMENTAL DESIGN: This is a multicenter, single-arm, "window of opportunity" pilot study of exemestane (25 mg daily for 21-42 …

lab-animal 2011
International journal of molecular sciences ·doi:10.3390/ijms12021334

Claudin 4 is a cellular adhesion molecule that is frequently overexpressed in ovarian cancer and other epithelial cancers. In this study, we sought to determine whether the expression of claudin 4 is associated with outcome in ovarian cance…

other 2010
Journal of ovarian research ·doi:10.1186/1757-2215-3-21

BACKGROUND: New biomarkers that replace or are used in conjunction with the current ovarian cancer diagnostic antigen, CA125, are needed for detection of ovarian cancer in the presurgical setting, as well as for detection of disease recurre…

other 2010
American Journal of Clinical Pathology ·doi:10.1309/ajcpgxk0fr4mhihb

Early detection of ovarian cancer is difficult owing to the lack of specific and sensitive tests available. Previously, we found expression of nectin 4 to be increased in ovarian cancer compared with normal ovaries. Reverse transcriptase-po…